Dublin (IE) | 08 May 2018: The International Cytokine and Interferon Society (ICIS) announced today that the Seymour and Vivian Milstein Award has been bestowed on two world leaders in deciphering the role of innate immunity in the host immune response. Inflazome's Chief Scientific Officer Luke O’Neill, PhD and Thirumala-Devi Kanneganti, PhD will share the 2018 Seymour and Vivian Milstein Award for Excellence in Cytokine and Interferon Research (“The Milstein Award”).
The Milstein Award recognizes achievements by biomedical research scientists who have made outstanding contributions to cytokine and interferon research, either in a basic or applied field. “This year the prestigious Milstein Award is presented to two scientists who have made major advances in understanding how our bodies recognize and respond to invasion by pathogens, and how this response can go wrong. The discoveries of Dr. Kanneganti and Dr. O’Neill are of profound clinical benefit to the treatment of major diseases in both immunity and cancer,” said Dr. Nancy Reich Marshall, President of the ICIS.
The 30th “Milstein Award” ceremony will be held at Cytokines 2018, the 6th Annual Meeting of the International Cytokine & Interferon Society on Saturday, October 27, in Boston, USA.
Read the full ICIS press release here.
Read the full article